-
Entity
-
Individual
-
Location
-
C/O Gritstone Oncology, Inc., 5858 Horton Street, Suite 210, Emeryville, CA
-
Summary
-
The estimated net worth of Karin Jooss is at least $621K dollars as of June 11, 2024. Karin Jooss is the EVP, Head of Research and Development of Gritstone bio, Inc. and owns shares of Gritstone bio, Inc. (GRTS) stock worth about $511K. Karin Jooss is the Director of FATE THERAPEUTICS INC and owns shares of FATE THERAPEUTICS INC (FATE) stock worth about $109K.